TABLE 10.

Recommendations for resistance testing.

Regimen	DTG-based therapy	NNRTI-based therapy	PI-based therapy
First-line regimen	Recommended if the patient has been on regimen for > 2 years	Not routinely recommended	Not routinely recommended (rare scenario)
Second-line regimen	Recommended if the patient has been on regimen for > 2 years	Recommended (rare scenario)	Recommended if the patient has been on regimen for > 2 years

DTG, dolutegravir; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.